Home / Generics

Generics

News

EMA approves two generics for fungal infections posted 19/07/2019

On 29 May 2019, the European Medicine Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive o...

FDA approval for Unichem Lab’s hydrochloride medicines and Teva’s nasal spray to treat opioid overdose posted 08/07/2019

The US Food and Drug Administration (FDA) has granted Unichem Laboratories a tentative abbreviated new drug approval (ANDA) f...

Teva launches generic testosterone gel and overactive bladder treatment in the US posted 31/05/2019

In April 2019, Israeli generics giant Teva Pharmaceutical Industries (Teva) announced the launch of generic versions of Andro...

EMA approves hypertension and Parkinson’s generics posted 17/05/2019

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) announced on 26 April 2019 that i...

Stada launches generic Exforge following patent revocation posted 19/04/2019

German generics producer Stada Arzneimittel announced on 20 March 2019 that it is set to launch a generic version of the anti...

 

Research

Adherence to generic versus brand-name statins and associated clinical and economic outcomes posted 24/05/2019

Despite evidence supporting the efficacy of statins for the treatment and prevention of cardiovascular disease, a lack of adh...

Costs and prices of entecavir to treat Hepatitis B posted 17/05/2019

In an analysis of the costs and target prices of Hepatitis B treatment entecavir, author Andrew Hill from Liverpool Universit...

Mixed beliefs about generics among patients in a Malaysian hospital posted 03/05/2019

The Malaysian Government is heavily subsidizing public healthcare expenditure in order to provide access to health care for a...

Market evolution of new drug formulations posted 01/04/2019

Brand-name drug manufacturers sometimes create modified versions of their approved drugs which can include new strengths, dos...

Factors associated with increased side effects and lower perceived efficacy when switching to a generic posted 22/03/2019

In 2017, the New Zealand Pharmaceutical Management Agency (PHARMAC) changed the funded version of the antidepressant venlafax...

 

General

Gilead’s Truvada will face generics competition in 2020 posted 19/07/2019

Gilead Sciences’ HIV blockbuster Truvada will face generics competition in the US in 2020, a year earlier than expected.

Pharmacy benefit managers use spread pricing to increase profits in Michigan posted 07/06/2019

A report released in April 2019 raises new questions about the role of Pharmacy Benefit Managers (PBMs) in Michigan, specific...

Multi-state lawsuit alleges widespread generic price fixing in the US posted 20/05/2019

A sweeping lawsuit filed on 10 May 2019 by over 40 US states alleges that a number of major drug companies conspired to infla...

US Court rejects Teva’s lawsuit over generic Restasis posted 08/05/2019

The US District Court for the District of Columbia has discarded lawsuits from generics giant Teva Pharmaceutical Industries...

FDA releases statement on generic drug quality posted 15/04/2019

A statement released by the US Food and Drug Administration (FDA) responds to recent press reports of quality issues and outl...